Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Heart Arrest D006323 13 associated lipids
Cystitis D003556 23 associated lipids
Cholecystitis D002764 8 associated lipids
HIV Infections D015658 20 associated lipids
Subacute Sclerosing Panencephalitis D013344 3 associated lipids
Dermatitis, Allergic Contact D017449 20 associated lipids
AIDS Dementia Complex D015526 4 associated lipids
Constriction, Pathologic D003251 8 associated lipids
Medulloblastoma D008527 22 associated lipids
Zellweger Syndrome D015211 39 associated lipids
Coronary Thrombosis D003328 7 associated lipids
Glomerulonephritis, Membranous D015433 6 associated lipids
Peripheral Vascular Diseases D016491 8 associated lipids
Bronchopulmonary Dysplasia D001997 4 associated lipids
Hypertension, Portal D006975 12 associated lipids
Atherosclerosis D050197 85 associated lipids
Leukemia-Lymphoma, Adult T-Cell D015459 25 associated lipids
Metabolic Syndrome D024821 44 associated lipids
Dyslexia D004410 3 associated lipids
Leukemia, Eosinophilic, Acute D015472 3 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Klabunde RE and Anderson DE Role of nitric oxide and reactive oxygen species in platelet-activating factor-induced microvascular leakage. 2002 May-Jun J. Vasc. Res. pmid:12097822
Downing SJ et al. Effect of inflammatory mediators on the physiology of the human Fallopian tube. 2002 Hum Fertil (Camb) pmid:12082208
Jaracz S et al. Ginkgolides: selective acetylations, translactonization, and biological evaluation. 2002 J. Org. Chem. pmid:12076171
Tsuyuki K et al. Possible participation of intracellular platelet-activating factor in NF-kappaB activation in rat peritoneal macrophages. 2002 Biochim. Biophys. Acta pmid:12069846
Nakamura T et al. Relationship between the platelet activating factor acetylhydrolase gene and intractability of ulcerative colitis. 2002 Dis. Colon Rectum pmid:12068200
Yoshikawa M et al. Effect of extracellular matrix proteins on platelet-activating factor-induced eosinophil chemotaxis. 2002 Int. Arch. Allergy Immunol. pmid:12065903
Levine AS et al. A review of the effect of platelet-activating factor on male reproduction and sperm function. 2002 Jul-Aug J. Androl. pmid:12065449
Steel HC et al. Platelet-activating factor and lyso-PAF possess direct antimicrobial properties in vitro. 2002 APMIS pmid:12064871
Kingston JK et al. Effects of formaldehyde fixation on equine platelets using flow cytometric methods to evaluate markers of platelet activation. 2002 Am. J. Vet. Res. pmid:12061530
Silva-Neto MA et al. Platelet-activating factor (PAF) activates casein kinase 2 in the protozoan parasite Herpetomonas muscarum muscarum. 2002 Biochem. Biophys. Res. Commun. pmid:12054663
Kato T et al. Mitochondrial calcium response in human transformed lymphoblastoid cells. 2002 Life Sci. pmid:12052442
Zhou ZG and Chen YD Influencing factors of pancreatic microcirculatory impairment in acute panceatitis. 2002 World J. Gastroenterol. pmid:12046059
Lloberas N et al. Postischemic renal oxidative stress induces inflammatory response through PAF and oxidized phospholipids. Prevention by antioxidant treatment. 2002 FASEB J. pmid:12039876
Honda Z et al. Platelet-activating factor receptor. 2002 J. Biochem. pmid:12038971
Acuña AA et al. Fluticasone propionate attenuates platelet-activating factor-induced gas exchange defects in mild asthma. 2002 Eur. Respir. J. pmid:12030727
Sakai H et al. E3040 sulphate, a novel thromboxane synthase inhibitor, blocks the Cl- secretion induced by platelet-activating factor in isolated rat colon. 2002 Br. J. Pharmacol. pmid:12023941
Iatrou C et al. Is platelet-activating factor produced during hemodialysis with AN-69 polyacrylonitrile membrane? 2002 Nephron pmid:12021524
Michalis LK et al. Platelet hyperaggregability to platelet activating factor (PAF) in non-ST elevation acute coronary syndromes. 2002 Curr Med Res Opin pmid:12017208
Ottino P et al. Platelet-activating factor induces the gene expression of TIMP-1, -2, and PAI-1: imbalance between the gene expression of MMP-9 and TIMP-1 and -2. 2002 Exp. Eye Res. pmid:12014920
Zhang J et al. Effect of buyang huanwu decoction on platelet activating factor content in arterial blood pre- and post-arterial thrombosis in rats. 2001 J Tradit Chin Med pmid:12014136
Benito E and Bosch MA Role of platelet-activating factor in phosphatidylcholine secretion in primary cultures of rat type II pneumocytes. 2002 Prostaglandins Other Lipid Mediat. pmid:12013527
Zimmerman GA et al. The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis. 2002 Crit. Care Med. pmid:12004251
Barbuti A et al. Block of the background K(+) channel TASK-1 contributes to arrhythmogenic effects of platelet-activating factor. 2002 Am. J. Physiol. Heart Circ. Physiol. pmid:12003807
McManus LM and Pinckard RN PAF, a putative mediator of oral inflammation. 2000 Crit. Rev. Oral Biol. Med. pmid:12002818
Kalkanci A et al. The role of tumour necrosis factor-alpha (TNF-alpha) and platelet-activating factor (PAF) interaction on murine candidosis. 2002 Mycoses pmid:12000505
Borgquist JD et al. Adhesion to extracellular matrix proteins modulates bovine neutrophil responses to inflammatory mediators. 2002 J. Leukoc. Biol. pmid:11994500
Varon D and Brill A Platelets cross-talk with tumor cells. 2001 Haemostasis pmid:11990484
Börjesson A et al. Early treatment with lexipafant, a platelet-activating factor-receptor antagonist, is not sufficient to prevent pulmonary endothelial damage after intestinal ischaemia and reperfusion in rats. 2002 Dig Liver Dis pmid:11990391
Wang LS et al. Effects of platelet activating factor, butyrate and interleukin-6 on cyclooxygenase-2 expression in human esophageal cancer cells. 2002 Scand. J. Gastroenterol. pmid:11989839
Kolaczkowska E et al. Early vascular permeability in murine experimental peritonitis is co-mediated by resident peritoneal macrophages and mast cells: crucial involvement of macrophage-derived cysteinyl-leukotrienes. 2002 Inflammation pmid:11989789
Jerkić M et al. The mechanism of increased renal susceptibility to toxic substances in the elderly. Part I. The role of increased vasoconstriction. 2001 Int Urol Nephrol pmid:11989542
de Souza LJ et al. Effect of platelet-activating factor antagonists (BN-52021, WEB-2170, and BB-882) on bacterial translocation in acute pancreatitis. 2001 Jul-Aug J. Gastrointest. Surg. pmid:11985976
Roudebush WE et al. Embryonic platelet-activating factor: an indicator of embryo viability. 2002 Hum. Reprod. pmid:11980756
McKay CJ Recent developments in the management of acute pancreatitis. 2002 Dig Surg pmid:11979001
Steel HC and Anderson R Dissociation of the PAF-receptor from NADPH oxidase and adenylate cyclase in human neutrophils results in accelerated influx and delayed clearance of cytosolic calcium. 2002 Br. J. Pharmacol. pmid:11976271
Boisfer E et al. Antioxidant properties of HDL in transgenic mice overexpressing human apolipoprotein A-II. 2002 J. Lipid Res. pmid:11971944
Hostettler ME et al. Platelet-activating factor induces cell death in cultured astrocytes and oligodendrocytes: involvement of caspase-3. 2002 Glia pmid:11968060
Bernatchez PN et al. Relative effects of VEGF-A and VEGF-C on endothelial cell proliferation, migration and PAF synthesis: Role of neuropilin-1. 2002 J. Cell. Biochem. pmid:11968003
Castellvi J et al. Effect of the platelet-activating factor antagonist BN-52021 on liver preservation (4 degrees): experimental study in isolated reperfused rat liver model. 2002 Transplant. Proc. pmid:11959181
Lloberas N et al. The ether phospholipids trail: blood timing in renal ischemia-reperfusion injury. 2002 Transplant. Proc. pmid:11959179
Fragopoulou E et al. Biologically active lipids with antiatherogenic properties from white wine and must. 2002 J. Agric. Food Chem. pmid:11958642
Calcerrada MC et al. PAF-stimulated protein tyrosine phosphorylation in hippocampus: involvement of NO synthase. 2002 Neurochem. Res. pmid:11958533
Roudebush WE et al. Embryonic platelet-activating factor: temporal expression of the ligand and receptor. 2002 J. Assist. Reprod. Genet. pmid:11958508
Xu N et al. Effects of platelet-activating factor, tumor necrosis factor, and interleukin-1alpha on the expression of apolipoprotein M in HepG2 cells. 2002 Biochem. Biophys. Res. Commun. pmid:11944906
Strait RT et al. Pathways of anaphylaxis in the mouse. 2002 J. Allergy Clin. Immunol. pmid:11941316
Deo DD et al. Phosphorylation of STAT-3 in response to basic fibroblast growth factor occurs through a mechanism involving platelet-activating factor, JAK-2, and Src in human umbilical vein endothelial cells. Evidence for a dual kinase mechanism. 2002 J. Biol. Chem. pmid:11940567
Kingston JK et al. Measurement of the activation of equine platelets by use of fluorescent-labeled annexin V, anti-human fibrinogen antibody, and anti-human thrombospondin antibody. 2002 Am. J. Vet. Res. pmid:11939312
Tachibana A et al. Respiratory syncytial virus enhances the expression of CD11b molecules and the generation of superoxide anion by human eosinophils primed with platelet-activating factor. 2002 Intervirology pmid:11937770
Silva AR et al. Monocyte chemoattractant protein-1 and 5-lipoxygenase products recruit leukocytes in response to platelet-activating factor-like lipids in oxidized low-density lipoprotein. 2002 J. Immunol. pmid:11937571
Ahamed J and Ali H Distinct roles of receptor phosphorylation, G protein usage, and mitogen-activated protein kinase activation on platelet activating factor-induced leukotriene C(4) generation and chemokine production. 2002 J. Biol. Chem. pmid:11934880
Larrucea S et al. Agonist-induced aggregation of Chinese hamster ovary cells coexpressing the human receptors for fibrinogen (integrin alphaIIbbeta3) and the platelet-activating factor: dissociation between adhesion and aggregation. 2002 Blood pmid:11929771
Barletta E et al. Platelet activating factor inhibits the expression of matrix metalloproteinases and affects invasiveness and differentiation in a system of human neuroblastoma clones. 2002 Biol. Chem. pmid:11928813
Hostettler ME and Carlson SL PAF antagonist treatment reduces pro-inflammatory cytokine mRNA after spinal cord injury. 2002 Neuroreport pmid:11924887
Cellai C et al. Specific PAF antagonist WEB-2086 induces terminal differentiation of murine and human leukemia cells. 2002 FASEB J. pmid:11923217
Ozgün H et al. Lexipafant inhibits postsurgical adhesion formation. 2002 J. Surg. Res. pmid:11922727
Hu G et al. Isoflurane inhibits neutrophil-endothelium interactions in the coronary circulation: lack of a role for adenosine triphosphate-sensitive potassium channels. 2002 Anesth. Analg. pmid:11916783
Ishiguro K et al. Bisxanthones from Hypericum japonicum: inhibitors of PAF-induced hypotension. 2002 Planta Med. pmid:11914965
Ko HM et al. Nuclear factor kappaB dependency of platelet-activating factor-induced angiogenesis. 2002 Cancer Res. pmid:11912159
Royal SJ et al. Laminar disorganisation of mitral cells in the olfactory bulb does not affect topographic targeting of primary olfactory axons. 2002 Brain Res. pmid:11911856
Schwartzkopff F et al. The CXC chemokine NAP-2 mediates differential heterologous desensitization of neutrophil effector functions elicited by platelet-activating factor. 2002 J. Interferon Cytokine Res. pmid:11911809
McClenahan DJ et al. In vitro evaluation of the role of platelet-activating factor and interleukin-8 in Mannheimia haemolytica-induced bovine pulmonary endothelial cell injury. 2002 Am. J. Vet. Res. pmid:11911574
Matorras R and Pijoan JI The improvement in pregnancy rates with platelet-activating factor in intrauterine insemination was not demonstrated. 2002 Am. J. Obstet. Gynecol. pmid:11904634
Kondratskaya EL et al. BN52021, a platelet activating factor antagonist, is a selective blocker of glycine-gated chloride channel. 2002 Neurochem. Int. pmid:11900860
Mitsuoka H et al. Protease inhibition in the intestinal lumen: attenuation of systemic inflammation and early indicators of multiple organ failure in shock. 2002 Shock pmid:11900339
Bulger EM et al. The macrophage response to endotoxin requires platelet activating factor. 2002 Shock pmid:11900334
Teruel MN and Meyer T Parallel single-cell monitoring of receptor-triggered membrane translocation of a calcium-sensing protein module. 2002 Science pmid:11884760
Klein A et al. Platelet-activating factor drives eotaxin production in an allergic pleurisy in mice. 2002 Br. J. Pharmacol. pmid:11877329
Mio T et al. Lysophosphatidic acid augments fibroblast-mediated contraction of released collagen gels. 2002 J. Lab. Clin. Med. pmid:11873241
Tanaka Y et al. Anti-CD44 monoclonal antibody (IM7) induces murine systemic shock mediated by platelet activating factor. 2002 J. Autoimmun. pmid:11869042
Küçükhüseyin C et al. Renovascular actions of adenosine in the isolated perfused rat kidney: possible underlying mechanisms. 2001 J Basic Clin Physiol Pharmacol pmid:11868905
Breschi MC et al. Protective effect of silymarin in antigen challenge- and histamine-induced bronchoconstriction in in vivo guinea-pigs. 2002 Eur. J. Pharmacol. pmid:11864645
Ottino P and Bazan HE Corneal stimulation of MMP-1, -9 and uPA by platelet-activating factor is mediated by cyclooxygenase-2 metabolites. 2001 Curr. Eye Res. pmid:11840344
Barabé F et al. Cholesterol-modulating agents selectively inhibit calcium influx induced by chemoattractants in human neutrophils. 2002 J. Biol. Chem. pmid:11839753
Tibiriçá E Cardiovascular properties of yangambin, a lignan isolated from Brazilian plants. 2001 Cardiovasc Drug Rev pmid:11830750
Claing A et al. Comparison of the contractile and calcium-increasing properties of platelet-activating factor and endothelin-1 in the rat mesenteric artery and vein. 2002 Br. J. Pharmacol. pmid:11815379
Cao YZ et al. Selenium modulates 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (PAF) biosynthesis in bovine aortic endothelial cells. 2001 Antioxid. Redox Signal. pmid:11813988
Drost EM and MacNee W Potential role of IL-8, platelet-activating factor and TNF-alpha in the sequestration of neutrophils in the lung: effects on neutrophil deformability, adhesion receptor expression, and chemotaxis. 2002 Eur. J. Immunol. pmid:11813158
Johansson S et al. A neutrophil multitarget functional bioassay to detect anti-inflammatory natural products. 2002 J. Nat. Prod. pmid:11809061
Unno N et al. Association of a G994 -->T missense mutation in the plasma platelet-activating factor acetylhydrolase gene with risk of abdominal aortic aneurysm in Japanese. 2002 Ann. Surg. pmid:11807372
Ribeiro JM and Francischetti IM Platelet-activating-factor-hydrolyzing phospholipase C in the salivary glands and saliva of the mosquito Culex quinquefasciatus. 2001 J. Exp. Biol. pmid:11807106
Walterscheid JP et al. Platelet-activating factor, a molecular sensor for cellular damage, activates systemic immune suppression. 2002 J. Exp. Med. pmid:11805144
Cheminade C et al. 1-O-alkylglycerols improve boar sperm motility and fertility. 2002 Biol. Reprod. pmid:11804958
Shah BH et al. Molecular mechanisms involved in human platelet aggregation by synergistic interaction of platelet-activating factor and 5-hydroxytryptamine. 2001 Exp. Mol. Med. pmid:11795484
Roudebush WE et al. Relationship between platelet-activating factor concentration in rhesus monkey (Macaca mulatta) spermatozoa and sperm motility. 2002 Am. J. Primatol. pmid:11793409
Nagase T et al. Airway hyperresponsiveness in transgenic mice overexpressing platelet activating factor receptor is mediated by an atropine-sensitive pathway. 2002 Am. J. Respir. Crit. Care Med. pmid:11790655
Ohshima N et al. Receptor-dependent metabolism of platelet-activating factor in murine macrophages. 2002 J. Biol. Chem. pmid:11786559
Hiran T et al. Evidence for the involvement of the NADPH oxidase enzyme complex in the optimal accumulation of Platelet-activating factor in the human cell line PLB-985. 2001 Prostaglandins Other Lipid Mediat. pmid:11785782
Hanada K et al. Plasmodium falciparum phospholipase C hydrolyzing sphingomyelin and lysocholinephospholipids is a possible target for malaria chemotherapy. 2002 J. Exp. Med. pmid:11781362
Ichinowatari G et al. Participation of prostaglandin E2 and platelet-activating factor in thapsigargin-induced production of interleukin-6. 2002 Eur. J. Pharmacol. pmid:11779582
Zhu W et al. Effects of platelet activating factor antagonist (BN50739) on gut mucosal injury in acute severe pancreatitis in pigs. 2000 Chin. Med. J. pmid:11776064
Añel RL and Kumar A Experimental and emerging therapies for sepsis and septic shock. 2001 Expert Opin Investig Drugs pmid:11772263
Closa D et al. Absorption and effects of 3-(N-phenylamino)-1,2-propanediol esters in relation to toxic oil syndrome. 2001 Lipids pmid:11768157
Rivera A et al. Modulation of Gardos channel activity by cytokines in sickle erythrocytes. 2002 Blood pmid:11756192
Uhlmann D et al. Importance of microcirculatory disturbances in the pathogenesis of pancreatitis. 2001 Zentralbl Chir pmid:11753796
Haynes J and Obiako B Activated polymorphonuclear cells increase sickle red blood cell retention in lung: role of phospholipids. 2002 Am. J. Physiol. Heart Circ. Physiol. pmid:11748055
Stangl V et al. Negative inotropic mediators released from the heart after myocardial ischaemia-reperfusion. 2002 Cardiovasc. Res. pmid:11744010
Binisti C et al. Structure-activity relationships in platelet-activating factor (PAF). 11-From PAF-antagonism to phospholipase A(2) inhibition: syntheses and structure-activity relationships in 1-arylsulfamido-2-alkylpiperazines. 2001 Eur J Med Chem pmid:11738488
McHowat J et al. Endothelial cell PAF synthesis following thrombin stimulation utilizes Ca(2+)-independent phospholipase A(2). 2001 Biochemistry pmid:11732912
de Meis L Role of the sarcoplasmic reticulum Ca2+-ATPase on heat production and thermogenesis. 2001 Biosci. Rep. pmid:11725862
Caplan MS and Jilling T The role of polyunsaturated fatty acid supplementation in intestinal inflammation and neonatal necrotizing enterocolitis. 2001 Lipids pmid:11724457